Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.38 Million USD | 81.7% |
| 2022 | -13.05 Million USD | -267.8% |
| 2021 | -3.54 Million USD | -1784.31% |
| 2020 | -188.35 Thousand USD | -42.35% |
| 2019 | -132.31 Thousand USD | 52.62% |
| 2018 | -279.24 Thousand USD | 92.53% |
| 2017 | -3.73 Million USD | -378.73% |
| 2016 | -780.36 Thousand USD | -194.4% |
| 2015 | 826.69 Thousand USD | 267.35% |
| 2014 | 225.04 Thousand USD | -92.94% |
| 2013 | 3.18 Million USD | 236.46% |
| 2012 | -2.33 Million USD | -473.45% |
| 2011 | -407.53 Thousand USD | 91.26% |
| 2010 | -4.66 Million USD | -165.2% |
| 2009 | -1.75 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 18.9 Thousand USD | 103.27% |
| 2024 Q2 | 125.23 Thousand USD | 562.53% |
| 2023 FY | -2.38 Million USD | 81.7% |
| 2023 Q1 | -737.5 Thousand USD | 22.95% |
| 2023 Q2 | -560.15 Thousand USD | 24.05% |
| 2023 Q3 | -607.13 Thousand USD | -8.39% |
| 2023 Q4 | -577.76 Thousand USD | 4.84% |
| 2022 Q3 | -7.35 Million USD | -1892.78% |
| 2022 FY | -13.05 Million USD | -267.8% |
| 2022 Q1 | -4.35 Million USD | -457.61% |
| 2022 Q2 | -368.98 Thousand USD | 91.53% |
| 2022 Q4 | -957.12 Thousand USD | 86.98% |
| 2021 Q2 | -540.8 Thousand USD | 18.39% |
| 2021 FY | -3.54 Million USD | -1784.31% |
| 2021 Q3 | -13.03 Thousand USD | 97.59% |
| 2021 Q4 | -780.97 Thousand USD | -5889.96% |
| 2021 Q1 | -662.63 Thousand USD | -638.85% |
| 2020 Q4 | -89.68 Thousand USD | 76.42% |
| 2020 FY | -188.35 Thousand USD | -42.35% |
| 2020 Q3 | -380.26 Thousand USD | -1081.82% |
| 2020 Q2 | 38.73 Thousand USD | 271.38% |
| 2020 Q1 | -22.59 Thousand USD | 72.69% |
| 2019 Q4 | -82.76 Thousand USD | 28.4% |
| 2019 Q1 | -74.97 Thousand USD | -789.7% |
| 2019 Q2 | -177.03 Thousand USD | -136.13% |
| 2019 Q3 | -115.59 Thousand USD | 34.71% |
| 2019 FY | -132.31 Thousand USD | 52.62% |
| 2018 Q3 | 165.25 Thousand USD | 169.15% |
| 2018 FY | -279.24 Thousand USD | 92.53% |
| 2018 Q4 | -8427.00 USD | -105.1% |
| 2018 Q2 | -238.99 Thousand USD | -21.27% |
| 2018 Q1 | -197.07 Thousand USD | -1365.34% |
| 2017 Q1 | -3.61 Million USD | -767.75% |
| 2017 Q2 | -283.02 Thousand USD | 92.18% |
| 2017 Q3 | 143.02 Thousand USD | 150.54% |
| 2017 Q4 | -13.44 Thousand USD | -109.4% |
| 2017 FY | -3.73 Million USD | -378.73% |
| 2016 Q3 | -146.9 Thousand USD | -275.58% |
| 2016 Q4 | -416.96 Thousand USD | -183.83% |
| 2016 FY | -780.36 Thousand USD | -194.4% |
| 2016 Q1 | -177.38 Thousand USD | -114.49% |
| 2016 Q2 | -39.11 Thousand USD | 77.95% |
| 2015 Q1 | -61.99 Thousand USD | -2626.2% |
| 2015 Q2 | -114.39 Thousand USD | -84.53% |
| 2015 Q3 | -221.43 Thousand USD | -93.56% |
| 2015 Q4 | 1.22 Million USD | 653.0% |
| 2015 FY | 826.69 Thousand USD | 267.35% |
| 2014 Q1 | 346.02 Thousand USD | 217.64% |
| 2014 Q4 | 2454.00 USD | 105.06% |
| 2014 Q2 | -74.98 Thousand USD | -121.67% |
| 2014 FY | 225.04 Thousand USD | -92.94% |
| 2014 Q3 | -48.45 Thousand USD | 35.38% |
| 2013 Q3 | 105.39 Thousand USD | -96.88% |
| 2013 Q2 | 3.37 Million USD | 1206.29% |
| 2013 Q1 | -304.93 Thousand USD | 4.61% |
| 2013 FY | 3.18 Million USD | 236.46% |
| 2013 Q4 | -294.14 Thousand USD | -379.1% |
| 2012 Q3 | 1.08 Million USD | 162.13% |
| 2012 Q2 | -1.75 Million USD | -29.24% |
| 2012 Q4 | -319.67 Thousand USD | -129.39% |
| 2012 FY | -2.33 Million USD | -473.45% |
| 2012 Q1 | -1.35 Million USD | -682.98% |
| 2011 Q4 | 232.33 Thousand USD | 391.67% |
| 2011 FY | -407.53 Thousand USD | 91.26% |
| 2011 Q3 | -79.65 Thousand USD | 83.86% |
| 2011 Q2 | -493.42 Thousand USD | -638.73% |
| 2011 Q1 | -66.79 Thousand USD | 90.68% |
| 2010 Q2 | -19.91 Million USD | -2435.31% |
| 2010 FY | -4.66 Million USD | -165.2% |
| 2010 Q4 | -716.57 Thousand USD | -104.28% |
| 2010 Q3 | 16.75 Million USD | 184.13% |
| 2010 Q1 | -785.48 Thousand USD | -38.19% |
| 2009 Q1 | -305.28 Thousand USD | 0.0% |
| 2009 Q4 | -568.4 Thousand USD | -86.19% |
| 2009 Q2 | -383.87 Thousand USD | -25.74% |
| 2009 FY | -1.75 Million USD | 0.0% |
| 2009 Q3 | -305.28 Thousand USD | 20.47% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | -157.685% |
| Ansell Limited | 76.5 Million USD | 103.122% |
| Ansell Limited | 76.5 Million USD | 103.122% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 109.837% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | -46.51% |
| Psykey, Inc. | -1.32 Million USD | -80.404% |
| ConvaTec Group Plc | 130.3 Million USD | 101.833% |
| ConvaTec Group Plc | 130.3 Million USD | 101.833% |
| Encision Inc. | -691.78 Thousand USD | -245.262% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -1584.261% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -919.118% |
| Innovative MedTech Inc. | -7.93 Million USD | 69.914% |
| LifePoint, Inc. | -15.23 Million USD | 84.319% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 64.932% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | -403.896% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -770.287% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | -420.331% |
| SmileDirectClub, Inc. | -86.4 Million USD | 97.236% |
| Sector 10, Inc. | 7036.00 USD | 34046.376% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.119% |
| SheerVision, Inc. | -71.37 Thousand USD | -3246.317% |
| United Health Products, Inc. | -2.62 Million USD | 8.951% |
| Vasamed, Inc. | -4.88 Million USD | 51.138% |
| Yubo International Biotech Limited | -1.2 Million USD | -98.252% |